Dr. Peter Weinstein is an accomplished biotech executive, registered patent attorney, and co-founder. Peter brings over 35 years of experience in immunology, intellectual property, and business leadership. As CEO and Board Member, he guides Circurna’s strategy, leads a robust IP pipeline, and guides multidisciplinary teams from innovation to commercialization. Previously, Peter managed global IP portfolios for major therapeutics at Baxter Healthcare and advised hundreds of biotech companies as founder of Entralta, P.L.L.C. His dual expertise ensures that Circurna’s innovations are both pioneering and well-protected, strengthening the company’s competitive position in RNA therapeutics.